Care of Cancer Survivors: Distress and Mental Health.

Q3 Medicine FP essentials Pub Date : 2023-06-01
Marie Claire O'Dwyer
{"title":"Care of Cancer Survivors: Distress and Mental Health.","authors":"Marie Claire O'Dwyer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In 2022, it was estimated that 18.1 million US adults were cancer survivors. By 2032, this number is projected to increase to 22.5 million. All patients with cancer experience some degree of psychological distress associated with the diagnosis. This can include mental health conditions, most commonly anxiety and depression. Management of such conditions in cancer survivors begins with detection via screening. Commonly used screening tools include the National Comprehensive Cancer Network (NCCN) Distress Thermometer, the 7-item Generalized Anxiety Disorder (GAD-7) scale, and the Patient Health Questionnaire-9 (PHQ-9). Initial management involves patient education and psychotherapy. If needed, pharmacotherapy is similar to that for patients in the general population. Of note, several commonly prescribed antidepressants have been shown to decrease the effects of tamoxifen, which breast cancer survivors may be taking as adjuvant endocrine therapy. Integrative medicine therapies, such as music interventions, yoga, mindfulness meditation, and exercise, have shown benefit. Patients undergoing treatment should have outcomes assessed. Thoughts of self-harm or suicidal ideation are common among cancer survivors with mental health conditions. Clinicians should regularly ask patients about suicidal ideation. If present, this indicates the need for more intensive or altered treatment.</p>","PeriodicalId":38325,"journal":{"name":"FP essentials","volume":"529 ","pages":"7-13"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FP essentials","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

In 2022, it was estimated that 18.1 million US adults were cancer survivors. By 2032, this number is projected to increase to 22.5 million. All patients with cancer experience some degree of psychological distress associated with the diagnosis. This can include mental health conditions, most commonly anxiety and depression. Management of such conditions in cancer survivors begins with detection via screening. Commonly used screening tools include the National Comprehensive Cancer Network (NCCN) Distress Thermometer, the 7-item Generalized Anxiety Disorder (GAD-7) scale, and the Patient Health Questionnaire-9 (PHQ-9). Initial management involves patient education and psychotherapy. If needed, pharmacotherapy is similar to that for patients in the general population. Of note, several commonly prescribed antidepressants have been shown to decrease the effects of tamoxifen, which breast cancer survivors may be taking as adjuvant endocrine therapy. Integrative medicine therapies, such as music interventions, yoga, mindfulness meditation, and exercise, have shown benefit. Patients undergoing treatment should have outcomes assessed. Thoughts of self-harm or suicidal ideation are common among cancer survivors with mental health conditions. Clinicians should regularly ask patients about suicidal ideation. If present, this indicates the need for more intensive or altered treatment.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症幸存者的护理:痛苦和心理健康。
2022年,估计有1810万美国成年人是癌症幸存者。到2032年,这一数字预计将增加到2250万。所有癌症患者都会经历与诊断相关的某种程度的心理困扰。这可能包括精神健康状况,最常见的是焦虑和抑郁。对癌症幸存者的此类疾病的管理始于通过筛查进行检测。常用的筛查工具包括国家综合癌症网络(NCCN)痛苦温度计、7项广泛性焦虑障碍(GAD-7)量表和患者健康问卷-9 (PHQ-9)。初期治疗包括患者教育和心理治疗。如有需要,药物治疗与一般人群的药物治疗相似。值得注意的是,一些常用的抗抑郁药已被证明可以降低他莫昔芬的作用,乳腺癌幸存者可能将其作为辅助内分泌治疗。综合医学疗法,如音乐干预、瑜伽、正念冥想和锻炼,已经显示出了益处。接受治疗的患者应评估其预后。在有心理健康问题的癌症幸存者中,自残或自杀的想法很常见。临床医生应定期询问患者有关自杀念头的情况。如果出现,这表明需要更强化或改变治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
FP essentials
FP essentials Medicine-Medicine (all)
CiteScore
1.00
自引率
0.00%
发文量
58
期刊最新文献
Female Pelvic Conditions: Dyspareunia and Vulvodynia. Female Pelvic Conditions: Foreword. Female Pelvic Conditions: Interstitial Cystitis/Bladder Pain Syndrome. Female Pelvic Conditions: Sexually Transmitted Infections. Female Pelvic Conditions: Urinary Incontinence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1